CVS Health Corporation (CVS) Earnings History
Earnings Pressure37 years of earnings data (1989–2025) · 5-year EPS trend is negative
Loading earnings history...
CVS Health Corporation (CVS) Earnings Overview
As of June 21, 2026, CVS Health Corporation (CVS) reported trailing twelve-month net income of $2.93B, reflecting -62.0% year-over-year growth. The company earned $2.29 per diluted share over the past four quarters, with a net profit margin of 0.4%.
Looking at the long-term picture, CVS's 5-year EPS compound annual growth rate (CAGR) stands at -23.9%, signaling declining earnings. The company achieved its highest annual net income of $8.34B in fiscal 2023.
CVS Health Corporation maintains positive profitability with a gross margin of 13.8%, operating margin of 2.6%, and net margin of 0.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including UNH ($12.04B net income, 2.7% margin), CI ($6.29B net income, 2.2% margin), ELV ($5.24B net income, 2.8% margin), CVS has room to improve margins relative to the peer group. Compare CVS vs UNH →
CVS Earnings vs Peers
Earnings metrics vs comparable public companies
CVS Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.77B | -61.7% | $10.38B | $1.39 | 0.4% | 2.6% |
| 2024 | $4.61B | -44.7% | $8.52B | $3.66 | 1.2% | 2.3% |
| 2023 | $8.34B | +93.6% | $13.74B | $6.47 | 2.3% | 3.8% |
| 2022 | $4.31B | -46.1% | $7.95B | $3.26 | 1.3% | 2.5% |
| 2021 | $8.00B | +11.5% | $13.31B | $5.95 | 2.7% | 4.6% |
| 2020 | $7.18B | +8.2% | $13.91B | $5.46 | 2.7% | 5.2% |
| 2019 | $6.63B | +1216.8% | $11.99B | $5.08 | 2.6% | 4.7% |
| 2018 | -$594M | -109.0% | $4.02B | $-0.57 | -0.3% | 2.1% |
| 2017 | $6.62B | +24.5% | $9.54B | $6.44 | 3.6% | 5.2% |
| 2016 | $5.32B | +1.5% | $10.39B | $4.90 | 3.0% | 5.8% |
| 2015 | $5.24B | +12.8% | $9.47B | $4.63 | 3.4% | 6.2% |
| 2014 | $4.64B | +1.1% | $8.80B | $3.96 | 3.3% | 6.3% |
| 2013 | $4.59B | +18.8% | $8.04B | $3.74 | 3.6% | 6.3% |
| 2012 | $3.86B | +11.6% | $7.21B | $3.03 | 3.1% | 5.9% |
| 2011 | $3.46B | +1.0% | $6.33B | $2.57 | 3.2% | 5.9% |
| 2010 | $3.43B | -7.3% | $6.14B | $2.49 | 3.6% | 6.4% |
| 2009 | $3.70B | +15.1% | $6.42B | $2.55 | 3.8% | 6.5% |
| 2008 | $3.21B | +21.8% | $6.05B | $2.18 | 3.7% | 6.9% |
| 2007 | $2.64B | +92.6% | $4.79B | $1.92 | 3.5% | 6.3% |
| 2006 | $1.37B | +11.8% | $2.44B | $1.60 | 3.1% | 5.6% |
| 2005 | $1.22B | +33.3% | $2.02B | $1.45 | 3.3% | 5.5% |
| 2004 | $919M | +8.4% | $1.45B | $1.10 | 3.0% | 4.8% |
| 2003 | $847M | +18.2% | $1.42B | $1.03 | 3.2% | 5.4% |
| 2002 | $717M | +73.4% | $1.21B | $0.88 | 3.0% | 5.0% |
| 2001 | $413M | -44.6% | $771M | $0.50 | 1.9% | 3.5% |
| 2000 | $746M | +17.5% | $1.32B | $0.92 | 3.7% | 6.6% |
| 1999 | $635M | +65.2% | $1.14B | $0.78 | 3.5% | 6.3% |
| 1998 | $385M | +333.0% | $931M | $0.48 | 2.5% | 6.1% |
| 1997 | $89M | -57.3% | $704M | $0.10 | 0.6% | 5.1% |
| 1996 | $208M | +136.3% | $605M | $0.26 | 1.8% | 5.1% |
| 1995 | -$573M | -286.3% | $396M | $-1.52 | -5.9% | 4.1% |
| 1994 | $308M | -7.3% | $611M | $0.69 | 2.7% | 5.4% |
| 1993 | $332M | +148.7% | $623M | $0.60 | 3.2% | 6.0% |
| 1992 | $133M | -61.5% | $361M | $0.28 | 1.3% | 3.5% |
| 1991 | $347M | -10.0% | $670M | $0.80 | 3.5% | 6.8% |
| 1990 | $385M | -3.2% | $664M | $0.90 | 4.4% | 7.6% |
| 1989 | $398M | - | $661M | $0.89 | 5.3% | 8.7% |
Download Data
Export CVS earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into CVS consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CVS — Frequently Asked Questions
Quick answers to the most common questions about buying CVS stock.
What is CVS earnings per share (EPS)?
CVS trailing twelve-month (TTM) diluted EPS is $2.29, reflecting -62.0% year-over-year growth. The 5-year EPS CAGR is -23.9%. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is CVS Health Corporation's net income?
CVS Health Corporation (CVS) trailing twelve-month net income is $2.9B as of 2025. Earnings declined -62.0% year-over-year. CVS Health Corporation has been profitable for 7 consecutive years.
Is CVS profitable?
Yes, CVS is profitable with a TTM net income of $2.9B and a net profit margin of +0.4%. CVS Health Corporation has generated profits for 7 consecutive years.
What is CVS's earnings growth rate?
CVS compound annual EPS growth rates (CAGR): 1-Year: -62.0%, 3-Year: -24.7%, 5-Year: -23.9%, 10-Year: -11.3%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are CVS's profit margins?
CVS Health Corporation net profit margin is +0.4%, operating margin is +2.6%, and gross margin is +13.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is +2.3%.
Is CVS growing earnings?
CVS earnings are declining — EPS fell -62.0% year-over-year. TTM net income dropped to $2.9B. This contrasts with the 5-year CAGR of -23.9%.
What was CVS's best earnings year?
CVS Health Corporation's highest annual net income on record is $8.3B, achieved in fiscal year 2023. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were CVS's earnings last quarter?
CVS's most recent reported quarter was Q1 2026. Net income was $2.9B with diluted EPS of $2.30. For a full breakdown of all quarters, see the quarterly earnings table on this page.